New research highlights how the gut microbiota modulates immune responses following radiotherapy, influencing cancer treatment outcomes. This evolving understanding reveals that microbiome composition can impact tumor microenvironment and systemic immunity. The findings underscore opportunities for microbiota-targeted interventions to enhance radiotherapy effectiveness and promote durable anti-tumor immunity. These insights pave the way for integrating microbiome science into comprehensive cancer care strategies.